Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta
about
Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsArrhythmogenic right ventricular dysplasia/cardiomyopathy type 1: a light on molecular mechanismsThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyRole of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cellsHuman uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarraysLiarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.Matrix production and remodeling as therapeutic targets for uterine leiomyomaRacial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.Early growth response-2 expression in uterine leiomyoma cells: regulation and functionUterine leiomyomas: individualizing the approach to a heterogeneous conditionThe role of progesterone signaling in the pathogenesis of uterine leiomyomaGrowth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsTransforming growth factor-beta 3 alters intestinal smooth muscle function: implications for gastroschisis-related intestinal dysfunction.Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomasSignaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for TherapyImmunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle.Epidemiology of Uterine Fibroids: From Menarche to Menopause.Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells.Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice.Progesterone receptor action in leiomyoma and endometrial cancer.Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma.Proteoglycans in Leiomyoma and Normal Myometrium: Abundance, Steroid Hormone Control, and Implications for Pathophysiology.The TGF-β Family in the Reproductive Tract.Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.Role of Transforming Growth Factor β in Uterine Fibroid Biology.Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach.Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression.
P2860
Q24567733-0A5CEAC2-7863-4E89-B8A8-EF6C8B3FABB7Q27690277-EBAEE19A-1FC1-4F16-BCCE-052199E65CFEQ29040166-32F00297-9DE0-41FF-A809-C6BDC93A17A5Q33569061-38435501-E3BF-44D4-8F46-FC68385FB892Q33570359-3C97CF61-D08F-412B-AA66-D475C5998433Q33801290-632CBA1D-37BA-4DD8-BFC8-5F4AC953D6D1Q33814953-549BA545-3AE7-442D-87BD-C018FA0DC223Q33964731-7A982C59-675E-45EC-9613-2514CE9081FFQ34086320-42BC5C42-0FDE-4B20-BAB4-357577D183E1Q34125193-3EE607C5-6BC9-4062-912B-98FF39E81CD6Q34195881-09B0AFA6-6BE5-44F4-ACB6-3FA85FC73184Q34223004-75585E4C-E6AB-4B78-A974-5EBF04987986Q34437666-801405F0-F5B3-4958-B486-161EF2901E94Q34674982-671476ED-0C34-4D6A-8858-A442ACFD5178Q34758625-6502113C-2ABE-46BD-87B8-2C3CBC04C8B9Q35126955-D1F389B9-4E3F-4A49-806C-24A9B070B000Q35149373-31275A6D-0EB5-44D0-8DA3-406F9BDB2065Q35249360-4430DF95-D00D-4928-BC0D-F9B7A949221EQ35328276-9656EF45-2B90-4C7E-B51C-1A38693E135AQ35594078-A0890D47-50B3-45B3-99F9-87BCCC7FDD76Q35617355-939A746E-23AB-404F-A41D-80D9DC8210BDQ35855640-77FDCD8C-2301-4EA4-A642-B86ACEDA87DCQ36230444-3B9AB97B-D07A-47D4-963A-D6A05AAF88BAQ36522644-4E5574B5-D2DF-4D38-A8CB-590547E4A9ACQ36525065-517AC8AD-8301-442E-AACE-B953FA60A7FAQ37029528-F8173180-F1ED-4637-81C7-4E60C09F790BQ37318625-8AC6930A-2992-4FCE-BF54-18ED1DA2984DQ37338412-FF38A02A-D362-42A3-98F3-F29668A8AFF3Q38793621-228953B1-6513-4631-8895-7787CB6144B3Q38831211-78AB1A23-1E15-4DA3-847C-909F1DAC632CQ38963328-73F8EE40-8BC9-41A7-9116-9BA8D5E9C416Q41660259-89F5E25B-16C7-45A1-8656-2C3FF65F41EFQ47096314-64FE62D4-767B-4DFC-96AA-DB0676BD30F7Q47217486-BB037160-0970-4FBD-B31F-026097FFE3C1Q47924723-2712AD67-1A8A-414C-B447-A8ACD9962EC5Q51740449-0B23F988-40AC-4AA5-8EE7-C0A7B15ED433
P2860
Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@ast
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en-gb
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@nl
type
label
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@ast
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en-gb
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@nl
prefLabel
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@ast
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en-gb
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@nl
P921
P356
P1476
Human leiomyoma smooth muscle ...... liferative effects of TGF beta
@en
P2093
P304
P356
10.1210/JCEM.86.2.7237
P407
P577
2001-02-01T00:00:00Z